List of Excipients in API lisinopril
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lisinopril
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp | PRINIVIL | lisinopril | 0006-0019 | DIBASIC CALCIUM PHOSPHATE DIHYDRATE | |
| Merck Sharp & Dohme Corp | PRINIVIL | lisinopril | 0006-0019 | MAGNESIUM STEARATE | |
| Merck Sharp & Dohme Corp | PRINIVIL | lisinopril | 0006-0019 | MANNITOL | |
| Merck Sharp & Dohme Corp | PRINIVIL | lisinopril | 0006-0019 | STARCH, CORN | |
| TWi Pharmaceuticals Inc | ZESTRIL | lisinopril | 24979-238 | DIBASIC CALCIUM PHOSPHATE DIHYDRATE | |
| TWi Pharmaceuticals Inc | ZESTRIL | lisinopril | 24979-238 | MAGNESIUM STEARATE | |
| TWi Pharmaceuticals Inc | ZESTRIL | lisinopril | 24979-238 | MANNITOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing lisinopril
Detailed excipient profiles for lisinopril
Excipient focus: ALUMINUM OXIDE
lisinopril drug variants containing ALUMINUM OXIDE
lisinopril drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
lisinopril drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
lisinopril drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: ANHYDROUS LACTOSE
lisinopril drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc(780779901) | lisinopril | 23155-876 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CALCIUM PHOSPHATE
lisinopril drug variants containing CALCIUM PHOSPHATE
lisinopril drug variants not containing CALCIUM PHOSPHATE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
lisinopril drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
lisinopril drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
lisinopril drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
lisinopril drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
Excipient focus: CITRIC ACID MONOHYDRATE
lisinopril drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | lisinopril | 52652-3001 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: COLLOIDAL SILICON DIOXIDE
lisinopril drug variants containing COLLOIDAL SILICON DIOXIDE
lisinopril drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CORN STARCH 3-E-DODECENYL SUCCINIC ANHYDRIDE MODIFIED
lisinopril drug variants containing CORN STARCH 3-E-DODECENYL SUCCINIC ANHYDRIDE MODIFIED
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | lisinopril | 0615-7639 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing CORN STARCH 3-E-DODECENYL SUCCINIC ANHYDRIDE MODIFIED
Excipient focus: CROSCARMELLOSE SODIUM
lisinopril drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Yiling Pharmaceutical Inc | lisinopril | 69117-1003 |
| Graviti Pharmaceuticals Private Limited | lisinopril | 69844-118 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
lisinopril drug variants containing CROSPOVIDONE
lisinopril drug variants not containing CROSPOVIDONE
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
lisinopril drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
lisinopril drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: FD&C BLUE NO. 1
lisinopril drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | lisinopril and hydrochlorothiazide | 0615-7581 |
| Bryant Ranch Prepack | lisinopril and hydrochlorothiazide | 63629-1679 |
| MedVantx Inc | lisinopril and hydrochlorothiazide | 66116-300 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
lisinopril drug variants containing FD&C BLUE NO. 2
lisinopril drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
lisinopril drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
lisinopril drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C RED NO. 40
lisinopril drug variants containing FD&C RED NO. 40
lisinopril drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 5
lisinopril drug variants containing FD&C YELLOW NO. 5
lisinopril drug variants not containing FD&C YELLOW NO. 5
Excipient focus: FERRIC OXIDE RED
lisinopril drug variants containing FERRIC OXIDE RED
lisinopril drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
lisinopril drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | lisinopril | 0615-8405 |
| Blenheim Pharmacal Inc | lisinopril | 10544-240 |
| STAT Rx USA LLC | lisinopril | 16590-307 |
| RxChange Co | lisinopril | 33358-213 |
| QPharma Inc | lisinopril | 42708-096 |
| QPharma Inc | lisinopril | 42708-176 |
| PD-Rx Pharmaceuticals Inc | lisinopril | 43063-074 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROCHLORIC ACID
lisinopril drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | lisinopril | 52652-3001 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing HYDROCHLORIC ACID
Excipient focus: LACTOSE MONOHYDRATE
lisinopril drug variants containing LACTOSE MONOHYDRATE
lisinopril drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
lisinopril drug variants containing MAGNESIUM STEARATE
lisinopril drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | lisinopril | 52652-3001 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
lisinopril drug variants containing MANNITOL
lisinopril drug variants not containing MANNITOL
Excipient focus: POVIDONE
lisinopril drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | lisinopril | 16590-307 |
| Wockhardt Limited | lisinopril | 55648-927 |
| Wockhardt USA LLC | lisinopril | 64679-927 |
| Graviti Pharmaceuticals Private Limited | lisinopril | 69844-118 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing POVIDONE
Excipient focus: POVIDONES
lisinopril drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Liberty Pharmaceuticals Inc | lisinopril | 0440-7674 |
| NCS HealthCare of KY Inc dba Vangard Labs | lisinopril | 0615-7639 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing POVIDONES
Excipient focus: SILICON DIOXIDE
lisinopril drug variants containing SILICON DIOXIDE
lisinopril drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
lisinopril drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | lisinopril | 52652-3001 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM CITRATE
lisinopril drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | lisinopril | 52652-3001 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
lisinopril drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | lisinopril | 52652-3001 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
lisinopril drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
lisinopril drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
lisinopril drug variants containing STARCH, CORN
lisinopril drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
lisinopril drug variants containing STARCH, PREGELATINIZED CORN
lisinopril drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: TALC
lisinopril drug variants containing TALC
lisinopril drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
lisinopril drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Graviti Pharmaceuticals Private Limited | lisinopril | 69844-118 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
lisinopril drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | lisinopril | 52652-3001 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing WATER
Excipient focus: XYLITOL
lisinopril drug variants containing XYLITOL
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | lisinopril | 52652-3001 |
| >Company | >Ingredient | >NDC |
lisinopril drug variants not containing XYLITOL
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
